| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |